Postoperative hypoxemia and hypercarbia in healthy dogs undergoing routine ovariohysterectomy or castration and receiving butorphanol or hydromorphone for analgesia

Journal of the American Veterinary Medical Association

Volumn 222, Issue 3, 2003, Pages 330-336

  Campbell, Vicki L ^a   Drobatz, Kenneth J ^a   Perkowski, Sandra Z ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACEPROMAZINE; BUTORPHANOL; CARBON DIOXIDE; GLYCOPYRRONIUM BROMIDE; HYDROMORPHONE; ISOFLURANE; THIOPENTAL;

ABDOMINAL HYSTERECTOMY; ANALGESIA; ANESTHESIA COMPLICATION; ARTERIAL GAS; ARTICLE; CARBON DIOXIDE TENSION; CASTRATION; DOG; DRUG SAFETY; ELECTIVE SURGERY; EXTUBATION; FEMALE; HYPERCAPNIA; HYPOXEMIA; LUNG TOXICITY; NONHUMAN; OVARIECTOMY; OXYGEN TENSION; PAIN ASSESSMENT; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION;

ANALGESICS, OPIOID; ANIMALS; ANOXEMIA; BLOOD GAS ANALYSIS; BUTORPHANOL; CARBON DIOXIDE; DOG DISEASES; DOGS; FEMALE; HYDROMORPHONE; HYPERCAPNIA; HYSTERECTOMY; MALE; ORCHIECTOMY; OVARIECTOMY; OXYGEN; PARTIAL PRESSURE; POSTOPERATIVE COMPLICATIONS;

ANIMALIA; CANIS FAMILIARIS;

EID: 0037305318     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.2003.222.330     Document Type: Article

References (41)

1. Comroe JH, Botelho S. The unreliability of cyanosis in the recognition of arterial anoxemia. Am J Med Sci 1947;214:1-6.
2. Morris RW, Buschman A, Warren DL, et al. The prevalence of hypoxemia detected by pulse oximetry during recovery from anesthesia. J Clin Monit 1988;4:16-20.
3. Smith DC, Canning JJ, Crul JF, et al. Pulse oximetry in the recovery room. Anaesthesia 1989;44:345-348.
4. American Society of Anesthesiologists Task Force on Postanesthetic Care. Practice guidelines for postanesthetic care. Anesthesiology 2002;96:742-752.
5. DiBenedetto RJ, Graves SA, Gravenstein N, et al. Pulse oximetry monitoring can change routine oxygen supplementation practices in the postanesthesia care unit. Anesth Analg 1994;78:365-368.
6. Jacobson JD, McGrath CJ, Smith EP. Cardiorespiratory effects of four opioid-tranquilizer combinations in dogs. Vet Surg 1994;23:299-306.
7. Pelligrino DA, Peterson RD, Henderson SK, et al. Comparative ventilatory effects of intravenous versus fourth cerebroventricular infusions of morphine sulfate in the unanesthetized dog. Anesthesiology 1989;71:250-259.
8. Berg RJ, Orton EC. Pulmonary function in dogs after intercostal thoracotomy: comparison of morphine, oxymorphone, and selective intercostal nerve block. Am J Vet Res 1986;47:471-474.
9. Trim CM. Cardiopulmonary effects of butorphanol tartrate in dogs. Am J Vet Res 1983;44:329-331.
10. Plumb DC. Butorphanol tartrate. In: Plumb DC, ed. Veterinary drug handbook. 4th ed. Ames, Iowa: Iowa State University Press, 2002;111-114.
11. Plumb DC. Hydromorphone. In: Plumb DC, ed. Veterinary drug handbook. 4th ed. Ames, Iowa: Iowa State University Press, 2002;420-422.
12. West JB. Ventilation-perfusion relationships. In: West JB, ed. Respiratory physiology - the essentials. 5th ed. Baltimore: The Williams & Wilkins Co, 1995;51-69.
13. Walters LM, Ogilvie GK, Salman MD, et al. Repeatability of energy expenditure measurements in clinically normal dogs by use of indirect calorimetry. Am J Vet Res 1993;54:1881-1885.
14. Ogilvie GK, Salman MD, Kesel ML, et al. Effect of anesthesia and surgery on energy expenditure determined by indirect calorimetry in dogs with malignant and nonmalignant conditions. Am J Vet Res 1996;57:1321-1326.
15. Conzemius MG, Hill CM, Sammarco JL, et al. Correlation between subjective and objective measures used to determine severity of postoperative pain in dogs. J Am Vet Med Assoc 1997;210:1619-1622.
16. Pircio AW, Gylys JA, Cavanagh RL, et al. The pharmacology of butorphanol, a 3,14-dihydroxymorphinan narcotic antagonist analgesic. Arch Int Pharmacodyn Ther 1976;220:231-257.
17. Tavakoli M, Corssen G, Caruso FS. Butorphanol and morphine: a double-blind comparison of their parenteral analgesic activity. Anesth Analg 1976;55:394-401.
18. Gutstein HB, Akil H. Opioid analgesics. In: Hardman JG, Limbird LE, Gilman AG, eds. Goodman and Gilman's the pharmacologic basis of therapeutics. 10th ed. New York: McGraw-Hill Medical Publishing Division, 2001;569-619.
19. Lawlor P, Turner K, Hanson J, et al. Dose ratio between morphine and hydromorphone in patients with cancer pain: a retrospective study. Pain 1997;72:79-85.
20. Hill JL, Zacny JP. Comparing the subjective, psychomotor, and physiological effects of intravenous hydromorphone and morphine in healthy volunteers. Psychopharmacology 2000;152:31-39.
21. Walton RS, Wingfield WE, Ogilvie GK, et al. Energy expenditure in 104 postoperative and traumatically injured dogs with indirect calorimetry. J Vet Emerg Crit Care 1996;6:71-79.
22. Nunn JF. Carbon dioxide. In: Nunn's applied respiratory physiology. 4th ed. Jordan Hill, Oxford: Butterworth-Heinemann Ltd, 1993;219-246.
23. Robinson RW, Zwillich CW. Hypoventilation central apnea, and disordered breathing patterns. In: Bone RC, ed. Pulmonary and critical care medicine. St Louis: Mosby Year Book Inc, 1998;Q1-1-Q1-8.
24. West JB. Ventilation. In: West JB, ed. Respiratory physiology - the essentials. 5th ed. Baltimore: The Williams & Wilkins Co, 1995;11-20.
25. Martin L. All you really need to know to interpret arterial blood gases. Malvern, Pa: Lea & Febiger, 1992;17.
26. Haskins SC. Blood gases and acid-base balance: clinical interpretation and therapeutic implications. In: Kirk RW, ed. Current veterinary therapy VIII. Philadelphia: WB Saunders Co, 1983;201-215.
27. Steffey EP. Inhalation anesthetics. In: Thurman JC, Tranquilli WJ, Benson GJ, eds. Lumb & Jones veterinary anesthesia. 3rd ed. Baltimore: The Williams & Wilkins Co, 1996;297-329.
28. Pfeffer M, Smyth RD, Pittman KA, et al. Pharmacokinetics of subcutaneous and intramuscular butorphanol in dogs. J Pharm Sci 1980;69:801-803.
29. Pascoe PJ. Opioid analgesics. Vet Clin North Am Small Anim Pract 2000;30:757-772.
30. Parab PV, Ritschel WA, Coyle DE, et al. Pharmacokinetics of hydromorphone after intravenous, peroral, and rectal administration to human subjects. Biopharm Drug Dispos 1988;9:187-199.
31. Vallner JJ, Stewart JT, Kotzan JA, et al. Pharmacokinetics and bioavailability of hydromorphone following intravenous and oral administration to human subjects. J Clin Pharmacol 1981;21:152-156.
32. Ali J, Khan TA. The comparative effects of muscle transection and median upper abdominal incisions on postoperative pulmonary function. Surg Gynecol Obstet 1979;148:863-866.
33. Vaughan RW, Engelhardt RC, Wise L. Postoperative hypoxemia in obese patients. Ann Surg 1974;180:877-882.
34. Harte PJ, Courtney DF, O'Sullivan EG, et al. Duration of anaesthesia and postoperative hypoxaemia. Irish J Med Sci 1982;151:169-174.
35. Kitamura H, Sawa T, Ikezono E. Postoperative hypoxemia: the contribution of age to the maldistribution of ventilation. Anesthesiology 1972;36:244-252.
36. Beydon L, Hassapopoulos J, Quera MA, et al. Risk factors for oxygen desaturation during sleep, after abdominal surgery. Br J Anaesth 1992;69:137-142.
37. Spence AA, Alexander JI. Mechanisms of postoperative hypoxaemia. Proc R Soc Med 1972;65:12-14.
38. Hopf H, Sessler DI. Routine postoperative oxygen supplementation. Anesth Analg 1994;79:615-616.
39. Knighton DR, Halliday B, Hunt TK. Oxygen as an antibiotic: the effect of inspired oxygen on infection. Arch Surg 1984;119:199-204.
40. Jonsson K, Jensen JA, Goodson WH III, et al. Assessment of perfusion in postoperative patients using tissue oxygen measurements. Br J Surg 1987;74:263-267.
41. DeWitte J, Sessler DI. Perioperative shivering: physiology and pharmacology. Anesthesiology 2002;96:467-484.